Abe C, Tanaka K, Iwata C, Morita H. Vestibular-mediated increase in central serotonin plays an important role in hypergravity-induced hypophagia in rats. J Appl Physiol 109: 1635-1643, 2010. First published September 16, 2010 doi:10.1152/japplphysiol.00515.2010.-Exposure to a hypergravity environment induces acute transient hypophagia, which is partially restored by a vestibular lesion (VL), suggesting that the vestibular system is involved in the afferent pathway of hypergravityinduced hypophagia. When rats were placed in a 3-G environment for 14 days, Fos-containing cells increased in the paraventricular hypothalamic nucleus, the central nucleus of the amygdala, the medial vestibular nucleus, the raphe nucleus, the nucleus of the solitary tract, and the area postrema. The increase in Fos expression was completely abolished or significantly suppressed by VL. Therefore, these regions may be critical for the initiation and integration of hypophagia. Because the vestibular nucleus contains serotonergic neurons and because serotonin (5-HT) is a key neurotransmitter in hypophagia, with possible involvement in motion sickness, we hypothesized that central 5-HT increases during hypergravity and induces hypophagia. To examine this proposition, the 5-HT concentrations in the cerebrospinal fluid were measured when rats were reared in a 3-G environment for 14 days. The 5-HT concentrations increased in the hypergravity environment, and these increases were completely abolished in rats with VL. Furthermore, a 5-HT2A antagonist (ketanserin) significantly reduced 3-G (120 min) load-induced Fos expression in the medial vestibular nucleus, and chronically administered ketanserin ameliorated hypergravity-induced hypophagia. These results indicate that hypergravity induces an increase in central 5-HT via the vestibular input and that this increase plays a significant role in hypergravity-induced hypophagia. The 5-HT2A receptor is involved in the signal transduction of hypergravity stress in the vestibular nucleus.
TRANSIENT HYPOPHAGIA and a reduction in body mass are wellknown responses to centrifugation-induced hypergravity (4, 21, 23) . At the onset of hypergravity, rats and mice exhibit a large reduction in food intake, which is gradually recovered until they resume a normal food intake within 2 wk of their initial exposure to hypergravity. This reduction in food intake is followed by a reduction in body mass, which remains lower than that of the control animals maintained at 1 G, even after their food intake is fully restored. This transient hypophagia and early reduction in body mass at the onset of hypergravity might be linked because the reduction in body mass can be mimicked in pair-fed rats in a 1-G environment (21) . Therefore, the hypergravity-induced reduction in body mass might involve two different mechanisms: an acute transient response and a chronic adaptive response. The latter is attributable to changes in metabolism and body composition, including reductions in adiposity, plasma leptin, and insulin despite normal glucose concentrations (23) . However, limited information is available regarding this acute transient hypophagia.
The effects of a hypergravity environment may be transduced by vestibular activation, bone and skeletal muscle load, body-fluid shift, and pressure changes, which then elicit physiological and pathophysiological responses (1, 8, 22, 25) . These putative afferent mechanisms could contribute to hypergravity-induced transient hypophagia. The hypergravity-induced reduction in food intake is partially abrogated in het mice, which lack macular otoconia and thus gravity receptor function. Consequently, the vestibular system may be involved in this hypophagia (4) . Because the vestibulum is a primary sensor of gravity and a key organ in the induction of motion sickness (7), hypergravity-induced hypophagia might be attributable to motion sickness.
The vestibular nucleus contains serotonergic neurons, and serotonin 2A (5-HT 2A ) receptors modify glutamate-induced neuronal activity (19) because the 5-HT 2A antagonist ketanserin reduces the firing rate of the vestibular nucleus. Because ketanserin improved motion-induced emesis in Suncus murinus (16) and because 5-HT is an important neurotransmitter in hypophagia (6, 12) , we hypothesized that central 5-HT is increased in a hypergravity environment via the vestibular input and then induces hypophagia. To test this hypothesis, we performed the following three experiments. First, we measured the food intake and Fos expression in vestibular-intact and vestibular-lesioned (VL) rats in a 3-G environment for 14 days. Second, we measured the 5-HT concentrations in the cerebrospinal fluid of vestibular-intact and VL rats. Third, we examined the effect of ketanserin on their food intake and Fos expression. Fos expression in the brain regions, which may be critical for the initiation and integration of hypophagia and motion sickness, was examined.
MATERIALS AND METHODS
The animals used in this study were maintained in accordance with the Guiding Principles for the Care and Use of Animals in the Field of Physiological Science of the Physiological Society of Japan. The experiments were approved by the Animal Research Committee of Gifu University. Male Sprague-Dawley rats weighing 230 -250 g (8-wk old, n ϭ 132) were used for the experiments.
Measurement of food intake and rear-up activity. Five days before the hypergravity experiments, we created a VL in 12 of 24 rats and performed a sham treatment in the remaining 12 rats. Anesthesia was induced with an enflurane (Abbott Japan, Osaka, Japan) inhalation via a face mask. Sodium arsanilate solution (100 mg/ml) or saline (sham treatment) was then injected into the bilateral middle-ear cavity (50 l/ear). The success of the VL was confirmed by observing the swimming behavior of the rats after they were gently placed in a small tub filled with warm water (1) . Rats with complete lesions were unable to determine the direction in which they had to swim to reach the water surface and continued to turn around under the water. After recovery for 5 days from the VL or sham treatment, the rats were divided into four groups: sham-1 G (sham-treated rats reared in a 1-G environment, n ϭ 6), VL-1 G (VL rats reared in a 1-G environment, n ϭ 6), sham-3 G (sham-treated rats reared in a 3-G environment, n ϭ 6), and VL-3 G (VL rats reared in a 3-G environment, n ϭ 6). All the rats were maintained in individual cages (20-cm width ϫ 36-cm length ϫ 18-cm height). The 3-G environment was induced by centrifugation, and the individual cages were set in a custom-made gondola-type rotating box (Shimadzu, Kyoto, Japan) for 14 days. During a daily 30 min break, the cages were cleaned, and the body mass, food intake, and water intake of the rats were measured. To prevent the rats from carrying the pellets away from the feedbox, a powdered food (CLEA Rodent Diet CE-2; CLEA Japan, Tokyo, Japan) was supplied with a special feedbox (Type MP; Oriental Yeast, Tokyo, Japan) that collected any spilled food. All the rats had access to food ad libitum, and the room temperature was maintained at 24 Ϯ 1°C with a 12-h:12-h light/dark cycle. To examine the vertical movements of the rats as an index of their activity, their movements were detected with an infrared sensor (SUNX, Aichi, Japan). The infrared sensors were aligned horizontal to and 16 cm above the floor, and the number of intersections of the infrared beam was counted.
Fos measurement of sham or VL rats. Sixty rats were prepared and sham (n ϭ 30) or VL (n ϭ 30) surgery was performed as described above. Five days after surgery, six sham-treated rats and six VL rats were anesthetized with pentobarbital sodium (50 mg/kg ip) and perfused transcardially with 200 ml of heparinized saline (containing 1,000 U of heparin sodium), followed by 200 ml of 4% paraformaldehyde in phosphate buffer. The brain was then removed and stored in 4% paraformaldehyde at 4°C. The remaining 24 sham-treated rats and 24 VL rats were placed in the centrifugation device and maintained in a 3-G environment, as described above. During the daily 30-min break, the cages were cleaned, and the food and water were refreshed. At the end of days 1 (24 h after the start of hypergravity), 4, 7, and 14, 24 sham-treated rats (n ϭ 6 at each time point) and 24 VL rats (n ϭ 6 at each time point) were killed and their brains removed as described above. All specimens were stored overnight in 20% sucrose in PBS at 4°C and then frozen in liquid nitrogen. Serial sections (30 m) were cut with a cryostat (Leica CM1850; Leica Instruments, Wetzlar, Germany). Fos-containing cells were identified with an anti-c-Fos antibody (c-Fos Ab-5; Merck, Darmstadt, Germany) and the 3,3=-diaminobenzidine reaction. Hypergravity-induced Fos expression was examined in the paraventricular hypothalamic nucleus (PVN), the central nucleus of the amygdala (CeA), the medial vestibular nucleus (MVe), the raphe nucleus (Raphe), the nucleus of the solitary tract (NTS), and the area postrema (AP). The numbers of Fos-positive cells were counted by a researcher who was not involved in this experiment.
Measurement of 5-HT in the cerebrospinal fluid. Twelve rats were prepared, and sham (n ϭ 6) or VL (n ϭ 6) surgery was performed as described above. Five days after surgery, all the rats were anesthetized with an enflurane inhalation via a face mask, and 50 l of cerebrospinal fluid was collected by cisternal puncture. On the following day, the rats were placed on the centrifugation device and maintained for 14 days in a 3-G environment, as described above. The collection of cerebrospinal fluid was repeated on days 1, 4, 7, and 14 after the commencement of hypergravity. These samples were collected during the daily 30-min break. The 5-HT concentrations in the cerebrospinal fluid were measured by high-performance liquid chromatography (HTEC-500; Eicom, Kyoto, Japan).
Effects of ketanserin on body mass and food intake.
To examine the role of the 5-HT 2A receptor in the suppression of food intake and body mass gain in a 3-G environment, food intake and body mass were measured with or without the chronic infusion of a 5-HT 2A antagonist. Twelve rats were anesthetized with pentobarbital sodium (50 mg/kg ip), treated with sham vestibular surgery, and implanted with an infusion pump (iPRECIO; Primetech, Tokyo, Japan). The catheter part of the infusion pump was placed in the abdominal cavity, and the main body of the infusion pump was placed in the subcutaneous space at the back of the neck. All the rats were maintained in their individual cages to recover from surgery until the day of the experiment. Penicillin G potassium (6,000 U/day) and buprenorphine (3 g/kg) were injected intramuscularly for 3 days after surgery. The infusion pump was programmed so that saline was infused at a flow rate of 3 l/h for 7 days after surgery, and the infusate was then changed to ketanserin [33.6 mg/ml in 30% dimethyl sulfoxide (Sigma, St Louis, MO); n ϭ 6] or vehicle (n ϭ 6) under anesthesia induced with an enflurane inhalation via a face mask. The flow rate of the ketanserin or vehicle infusion was 2.6 l/h. After 1 day had elapsed, the experiments were begun. Body mass, food intake, water intake, and daily rear-up activity were measured in a 1-G environment for 2 days and in a 3-G environment for 14 days, as described above.
To examine whether the effects of ketanserin and VL on food intake are additive or occlusive, additional experiments were conducted on 12 VL rats. The rats were prepared as described above. Ketanserin (n ϭ 6) or vehicle (n ϭ 6) was continuously infused, and their daily food and water intakes and body masses were measured, with 3-G loading for 7 days.
Fos expression in vehicle-and ketanserin-injected rats. We examined the effects of ketanserin on 3-G-induced Fos expression in the PVN, CeA, MVe, Raphe, NTS, and AP. All rats were anesthetized with pentobarbital sodium (50 mg/kg ip), and a polyethylene catheter (PE-50; Becton Dickinson, Sparks, MD) was inserted into the abdominal cavity. The catheter was exteriorized from the back of the neck and fixed by suture. Two days after surgery, vehicle (1.0 ml of 30% DMSO; n ϭ 6) or ketanserin (2 mg/kg in 1.0 ml of 30% DMSO, n ϭ 6) was injected through the catheter every 3 h (8 times). Twenty-four hours after the first injection of vehicle or ketanserin, all the rats were exposed to a 3-G environment for 120 min and then killed. Fos expression in the PVN, CeA, MVe, Raphe, NTS, and AP were examined as described above.
Statistical analysis. All data are presented as means Ϯ SD. The Steel-Dwass test was applied to the data in Table 1 and Figs. 1, 3, 4 , and 5. The Mann-Whitney U-test was applied in the data in Fig. 7 . The significance level for the post hoc test was set at P Ͻ 0.05.
RESULTS
To examine the role of the vestibular system on hypergravity-induced reductions in body mass and food intake, these variables were measured for 14 days in sham and VL rats in a 1-G or 3-G environment. The body masses immediately before the experiment were significantly smaller in the VL rats than in the sham-treated rats (Table 1) . However, there was no difference in the body mass gain between the sham-1 G and VL-1 G rats because the slope of the body mass change in the VL-1 G rats (4.9 Ϯ 0.3 g/day; Fig. 1, top, left) was similar to that in the Table 1 . Baseline body mass immediately before the 14-day experiment
Values are means Ϯ SE body mass for each group. Sham and vestibular lesion (VL) data record measurement of food intake and rear-up activity (n ϭ 6 in each group). Vehicle and ketanserin data record effects of ketanserin on body mass and food intake (n ϭ 6 in each group). Baseline body mass was measured just before the experiment. *P Ͻ 0.05 vs. sham-treated rats.
sham-1 G rats (4.7 Ϯ 0.3 g/day). In the 3-G environment, the body mass of the sham-treated rats decreased, reaching a minimum (Ϫ58 Ϯ 3 g) on day 5 of loading and then gradually recovered to the prehypergravity value (Ϫ8 Ϯ 6 g) on day 14 of loading. The suppressive effect of hypergravity on body mass was significantly attenuated by VL. In the VL-3 G rats, the body mass nadir was Ϫ14 Ϯ 2 g on day 1 but had increased by 41 Ϯ 6 g on day 14 .
Under 1-G conditions, the sham-treated rats reared up about 400 times per day, and this was not significantly affected by VL (Fig. 1, top, right) . The hypergravity load significantly suppressed the rear-up behavior. The daily rear-up counts for the sham-3 G and VL-3 G rats were significantly reduced relative to those of the sham-1 G and VL-1 G rats, respectively, although no differences were observed between the sham-3 G and VL-3 G rats.
Under 1-G conditions, the rats consumed 6 -7 g/100 g body mass of food daily and about 11 g/100 g body mass of water daily, and VL did not affect their daily food and water intakes (Fig. 1, bottom) . The hypergravity load significantly suppressed the rats' food and water intake. The sham-3 G rats consumed no food or water on days 1 and 2 and then recovered and reached the preload intake on day 6. The suppressive effects of hypergravity on food and water intake were significantly attenuated by VL. The VL-3 G rats consumed 2.4 Ϯ 0.5 g/100 g body mass of food and 2.1 Ϯ 0.6 g/100 g body mass of water, even on day 1 of hypergravity loading. Both food and water intakes were restored to the preload values on day 3 of hypergravity.
To examine the role of the vestibular system in hypergravity-induced central activation, Fos expression in the PVN, CeA, MVe, Raphe, NTS, and AP was compared between the sham and VL rats. Figure 2 shows typical photomicroscopic images of serial sections of the MVe, AP, and NTS from sham-treated and VL rats. The data for the numbers of Foslabeled cells are summarized in Fig. 3 . In the sham-treated rats, the numbers of Fos-labeled cells in the MVe increased significantly on days 1, 4, and 7 of hypergravity loading compared with those in the sham-treated rats under 1-G conditions. This increase was completely absent in the VL rats. The numbers of Fos-labeled cells in the CeA, Raphe, and AP increased significantly on days 1 and 4 of loading in the sham-treated rats, whereas no increase was observed in the VL rats. The numbers of Fos-labeled cells in the NTS only increased on day 1 of load in both the sham-treated and VL rats. Again, the increase was significantly greater in the sham-treated rats than in the VL rats. The numbers of Fos-labeled cells in the PVN were significantly increased in both the sham-treated and VL rats on day 1 of loading. A significant increase was also observed on day 4 of loading in the sham-treated rats, but no such increase was observed in the VL rats.
To examine the central 5-HT response to hypergravity, the 5-HT concentration in the cerebrospinal fluid was measured in sham and VL rats. The 5-HT concentrations were significantly increased on days 1, 4, and 7 of hypergravity but had returned to the preload value on day 14 (Fig. 4) . This increase in the 5-HT concentration was completely abolished by VL, i.e., the 5-HT concentrations in the VL-3 G rats were not altered by hypergravity loading.
To examine the effects of ketanserin on body mass and food intake in the hypergravity environment, we measured these variables for 14 days in the 3-G environment. This dose of ketanserin did not affect the baseline body mass or food and water intakes (Table 1 and Fig. 5 ). This was also supported by our preliminary experiments, in which the effects of ketanserin were examined in a 1-G environment for 7 days, and this dose of ketanserin infusion had no effect on the body mass or food and water intakes of the rats (data are not shown). In the vehicle-treated rats, the body mass gain was significantly suppressed by hypergravity loading, as in the sham-3 G rats in Fig. 1; i.e., the body mass decreased by 44 Ϯ 2 g from the preexperimental value on day 4 of hypergravity loading (Fig.  5A) . The suppressive effect of hypergravity on body mass was significantly attenuated by ketanserin; the nadir was Ϫ35 Ϯ 2 g on day 2, and the body mass had increased by 18 Ϯ 2 g on day 14 . In the 3-G environment, the daily rear-up counts were significantly suppressed in both the vehicle-and ketanserintreated rats, and there was no difference between the two groups. Hypergravity loading significantly reduced the rats' food and water intakes. No food or water was consumed on day 1 by the vehicle-treated rats, but they recovered, with the restoration of the preload values on day 9 for food and on day 5 for water. Ketanserin significantly attenuated the suppressive effects of hypergravity on the food and water intakes. Both food and water intakes were restored to the preload levels on day 4 of hypergravity loading.
To examine whether ketanserin had any further effects on ameliorating food intake in the VL rats, their food and water intakes and body mass were measured in the hypergravity environment with or without ketanserin infusion. No difference in body mass or food or water intake was observed between the ketanserin-and vehicle-treated groups (Fig. 5B) . These results suggest that the 5-HT 2A -mediated effects on feeding under hypergravity might be involved in the vestibular system. To examine whether hypergravity induced increases in Fos expression, even with ketanserin, we measured the Fos expression in vehicle-and ketanserin-injected rats. Figure 6 shows the typical photomicroscopic images of serial sections of the MVe, AP, and NTS from vehicle-and ketanserin-injected rats after 3-G loading for 120 min. Data for the numbers of Fos-labeled cells are summarized in Fig. 7 . The numbers of Fos-labeled cells were significantly suppressed in the CeA, MVe, and NTS in the ketanserin-injected rats.
DISCUSSION
The major findings of this study are as follows. 1) The dramatic reductions in body mass, food intake, and water intake seen in the sham-treated rats during 3-G loading were partially abrogated by VL. 2) 3-G loading increased the numbers of Fos-immunolabeled cells in the PVN, CeA, MVe, Raphe, NTS, and AP, and these increases were completely abolished or significantly attenuated by VL.
3) The 5-HT levels in the cerebrospinal fluid increased until day 7 of 3-G loading in the sham-treated rats but not in the VL rats. 4) Ketanserin attenuated the 120-min hypergravity-induced Fos expression in the CeA, MVe, and NTS but not in the PVN, Raphe, or AP. 5) The 3-G-induced reductions in body mass, food intake, and water intake were partially restored by a continuous infusion of ketanserin in the sham-treated rats, but ketanserin had no further effect on ameliorating food intake in the VL rats.
In the 1-G environment, there was no difference in the body mass gain between the sham-1 G and VL-1 G rats. In the 3-G environment, body mass decreased dramatically and reached a minimum on day 5 of loading in the sham-3 G rats. This reduction was partially but significantly abrogated in the VL-3 G rats. This suggests that the vestibular system participates in the body mass loss in a 3-G environment. In general, a difference in body mass gain and/or loss can be attributed to a difference in energy expenditure and/or a difference in energy supply (food intake). Energy expenditure, assessed by O 2 consumption and CO 2 production, is 40% higher in a hypergravity environment than in a 1-G environment, probably as the result of the increased body weight (body mass ϫ acceleration due to gravity) (31) . This may contribute to the reduction in body mass during hypergravity, but whether this contributed to the difference in body mass between the shamtreated and VL rats is unclear.
Although the precise energy expenditure was not measured in the present study, rear-up activity was suppressed in the 3-G environment in both the sham-treated and VL rats, and there was no difference between the two groups. This is supported by the observation of Fuller et al. (4), who found no difference in the daily activity of wild-type mice and het mice, which lack otoconia, in a 2-G environment. Therefore, the energy expenditure attributable to daily activity might have been similar in the sham-treated and VL rats. Conversely, food intake was suppressed in the sham-3 G rats, and this suppression was partially abrogated in the VL-3 G rats. Lintault et al. (21) reported that the body mass of pair-fed rats in a 1-G environment matched that of rats reared in a hypergravity environment. Therefore, the difference in body mass gain between the sham-3 G and VL-3 G rats might be predominantly attributable to differences in their food intakes.
Because 5-HT is one of the major neurotransmitters involved in ingestive behavior (6, 11, 12) , we measured the 5-HT concentration in the cerebrospinal fluid of the rats in the 3-G environment for 14 days. It was significantly increased in the sham-3 G rats on days 1, 4, and 7 of loading and was restored to the preload level on day 14. This time course is consistent with the time course of food intake, which was completely abolished on the first 1 or 2 days of loading and gradually recovered thereafter although it was still significantly suppressed on day 5 ( Fig. 1) and day 8 (Fig. 5 ) of loading. The increase in 5-HT in the cerebrospinal fluid was completely absent in the VL-3 G rats. These results suggest that hypergravity induced elevated 5-HT concentrations in the central nervous system via the vestibular input, and this then suppressed the food intake of the sham-treated rats.
We have clearly demonstrated that the hypergravity-induced Fos expression in the CeA, MVe, and NTS was significantly suppressed by ketanserin (Fig. 7) , and a continuous intraperitoneal infusion of ketanserin significantly ameliorated the reductions in food intake and body mass in the sham-treated rats (Fig. 5) . Thus the 5-HT 2A receptor is at least partly, if not exclusively, involved in the 5-HT-induced hypophagia during hypergravity loading. The activation of the 5-HT 2A receptor in the PVN is known to suppress neuropeptide-Y-induced hyperphagia (9) . However, the amelioration of hypophagia might not be attributable to the direct effect of ketanserin on the hypothalamic feeding center because this dose of ketanserin had no hyperphagic effect in the 1-G environment.
Another possible site of ketanserin action is the vestibular nucleus. The vestibular nucleus projects into the Raphe (2) and also receives 5-HT-containing projections from the Raphe (33). This backprojection might augment the activation of the vestibular nucleus via the 5-HT 2A receptor because the local application of 5-HT to the vestibular nucleus in vivo increases the firing rate, and this effect is suppressed by ketanserin (19, 20) . Therefore, the effect of ketanserin on food intake might be attributable to the inhibition of the backprojection-induced activation of the vestibular nucleus. Consistent with this, ketanserin significantly suppressed the hypergravity-induced Fos expression in the MVe, but not in the Raphe. This is further supported by the observation that the ketanserin infusion had no further effect on food intake in VL rats in the 3-G environment. It is difficult to determine whether rats suffer from motion sickness because they show no emetic response. However, using allotriophagy as an index of motion sickness, Uno et al. (27, 28) demonstrated hypergravity-induced motion sickness in rats. Because the vestibular system is involved in motion sickness (7, 27, 28) , it is assumed that hypergravity-induced motion sickness might have induced a reduction in food intake and then a corresponding reduction in body mass in the sham-3 G rats. Although the role of 5-HT in motion sickness is complex and remains to be clarified, the 5-HT-modulated activation of the vestibular nucleus might be involved in motion sickness. In fact, an intraperitoneal injection of ketanserin attenuates motion-induced emesis (16, 17) . The vestibular nucleus also contains the 5-HT 1A receptor, and the local application of the 5-HT 1A agonist 8-OH-DPAT suppresses the firing rate of the vestibular nucleus, improving motion-induced emesis (17, 18) . However, the 5-HT 1A receptor antagonist WAY100635 failed to modify the inhibitory action of 8-OH-DPAT. Furthermore, 5-HT agents act on neuronal acetylcholine receptors, which must be considered in addition to 5-HT receptor subtypes if we are to understand the role of 5-HT in motion sickness (5).
3-G loading induced a significant increase in Fos expression in the MVe on days 1, 4, and 7 in the sham-treated rats. This increase was completely absent in the VL-3 G rats, suggesting that the increase is induced by vestibular stimulation. Fos protein is first expressed when the neuron is activated, is maximally expressed within 2-4 h, and disappears within 6 -8 h (13, 26) . Therefore, the data from the present study suggest that continuous exposure to 3 G might continuously stimulate the peripheral vestibular organ and continuously activate the MVe for 7 days. No significant increase in Fos expression was observed on day 14 of loading. These changes in Fos expression in the MVe might account for the adaptation of the peripheral vestibular organ and/or the primary neurons of the vestibular system when the rats were exposed to a different gravitational environment (30) .
The AP is involved in the central pathway of drug-induced emesis. However, the functional role of the AP in the development of motion sickness is still controversial (15) . Because hypergravity induces no or only moderate Fos expression in the AP (10, 24) , it is thought that the AP is less strongly involved in motion sickness than in drug-induced emesis. However, in the present study, 3-G loading induced Fos expression in the AP on days 1 and 4 of loading, but this was completely abolished by VL. Therefore, it is possible that the AP is mainly activated via the vestibular system during 3-G loading. The major cause of this discrepancy in Fos expression in the AP may be the difference in the duration of hypergravity exposure. Gustave Dit Duflo et al. (10) used a 2-G or 4-G load for 90 min, and Nakagawa et al. (24) used a 2-G load for 3 h, whereas we used a 3-G load for 2 wk in the present study. The time course of Fos expression in the AP is consistent with the time course of both food intake and Fos expression in the CeA, which is thought to be a key neural substrate for both drug-and motion sickness-induced emetic and/or nausea responses (14, 29) . Taken together, these data suggest that the AP plays a significant role in both motion sickness-induced and drug-induced emesis. This finding must be clarified in a future study.
Increases in Fos expression in the NTS and PVN were also observed in the sham-3 G rats. These increases were significantly attenuated in the VL-3 G rats although the increases were still significant. Fuller et al. (3) also observed a significant increase in Fos expression in the PVN after 2-G loading, which was significantly suppressed in het mice. This suggests that these areas are mainly activated via the vestibular pathway although nonvestibular pathways are also involved to a lesser extent. Somatosensory, proprioceptive, and visceral inputs are thought to be included among the nonvestibular inputs induced by gravitational changes (32) . These nonvestibular inputs might project to the NTS and PVN and might then suppress food intake in VL-3 G rats. However, the nonvestibular pathways might rapidly adapt to the 3-G load because, in the VL-3 G rats, significant Fos expression was only observed on day 1 of loading and no significant increase was observed on day 4 of load. The rats' food intake was restored on day 3 of loading.
Limitations. Although ketanserin significantly ameliorated hypergravity-induced hypophagia, its effect was somewhat small compared with that of VL. Because a single dose of ketanserin was used and Fos expression was not examined in the long-term ketanserin infusion experiment, it is unclear whether the responses were only partially dependent on the 5-HT 2A receptor or whether a larger dose of ketanserin would have produced a more robust effect. Furthermore, 14 5-HT receptors were identified, so these interactions are complex (6) . Therefore, the involvement of other 5-HT receptors must be examined to fully understand the role of increased 5-HT in the cerebrospinal fluid. These requirements must be examined in a future study. Despite these limitations, the present study clearly demonstrates that hypergravity stress was transmitted to the vestibular nucleus via the 5-HT 2A receptor and then elicited transient hypophagia.
In conclusion, hypergravity induced an increase in central 5-HT via the vestibular system and elicited transient hypophagia. A chronic infusion of a 5-HT 2A antagonist improved this hypophagia. Therefore, 5-HT must play an important role in hypergravity-induced hypophagia.
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